Evidence map›Paper›PMID 40612703›Full record

ReviewReviews in chemical engineering2025

Trends and perspectives in deterministic MINLP optimization for integrated planning, scheduling, control, and design of chemical processes.

David A Liñán, Luis A Ricardez-Sandoval

Abstract readReview
In one paragraph

Review in Reviews in chemical engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

David A LiñánDepartment of Chemical Engineering, University of Waterloo, 200 University Ave W, Waterloo, ON, Canada.ORCID https://orcid.org/0000-0002-3190-7612
Luis A Ricardez-SandovalDepartment of Chemical Engineering, University of Waterloo, 200 University Ave W, Waterloo, ON, Canada.ORCID https://orcid.org/0000-0001-9867-6778

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mixed integer nonlinear programming (MINLP) in chemical engineering originated as a tool for solving optimal process synthesis and design problems. Since then, the application of MINLP has expanded to encompass control and operational decisions that are in line with the arising challenges faced by the industry, e.g., sustainability, competitive markets, and volatile supply chain environments. Nowadays, process plants are transitioning from traditional manufacturing practices to automated solutions able to integrate decision-making within manufacturing enterprises. This paradigm shift aims to increase profits, optimize resource utilization efficiency, promote long-term sustainability, minimize waste, and enhance responsiveness under uncertainties and perturbations. Accordingly, the development of reliable, computationally efficient, and robust MINLP algorithms capable of simultaneously handling process design, planning, scheduling, or control decisions are crucial to achieving Industry 4.0 integration goals. This work explores potential research opportunities and recent advances toward the development of integrated decision-making frameworks, focusing on their underlying state-of-the-art optimization tools. We provide an overview of emerging deterministic MINLP optimization algorithms for simultaneous decision-making problems. Furthermore, we constructively discuss the versatility and limitations of these optimization tools. We also highlight how novel optimization theories, both within and outside the chemical engineering domain, can be incorporated into advanced MINLP frameworks suitable for process integration.

Indexed as

controldesignoptimization; process integrationplanningscheduling

Identifiers

PMID40612703
PMCPMC12218914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.